therapy in the development of these cerebrovascular complications, which can occur at various stages
Asadullina, D.D.,
Gilyazova, I.R.,
Ivanova, E.A.,
Izmailova, S.M.,
Gilyazova, G.R.,
Pavlov, V.N.,
Khusnutdinova, E.K. (2024) . Disruption of miRNA regulation may affect ccRCC immunogenicity and response to ICI
therapy, making them